🥊 Two lobbies, one molecule, and 99 days to December 11th

Today's edition is sponsored by Apollo. Their support keeps these briefings free and focused on what actually matters.

The hemp delay is still one signature from law, and the fight over what replaces it opened anyway, with the state-licensed lobby promising December and Andy Barr's framework bill running four Republicans and four Democrats deep. In Boston, a jury needed three and a half hours to acquit Steven Tompkins on both counts. Aurora put a fairness opinion behind its no to Curaleaf. New York started paying for its own Metrc tags. And a new episode of The Hybrid is up: Erik Gundersen and I sit down with Eric Taubel of Minnesota's Office of Cannabis Management, the state at the center of the hemp-beverage fight Congress just gave itself a month to settle.

🥊 The feud names its terms
🧑‍⚖️ Three and a half hours
🗽 The state buys the tags

The continuing resolution is still one signature from law, and the December fight opened without waiting for it. The state-licensed industry's Washington arm staked its ground within hours of the House vote. "While we're disappointed, our sights are set on December," said Chris Lindsey of the American Trade Association for Cannabis and Hemp (ATACH), which lobbied against the extension and wants the November restrictions to land intact when the month runs out. The U.S. Hemp Roundtable's Jonathan Miller and others want the same deadline to deliver the opposite result, robust regulation in place of a ban, with age limits, manufacturing standards, and a crackdown on sales to minors. The paper both sides will negotiate from keeps accumulating. Rep. Andy Barr's Lawful Hemp Protection Act added Reps. James Baird and Betty McCollum this week, four Republicans and four Democrats deep. Rep. James Comer is circulating packaging, testing, and age-limit language, Reps. Beth Van Duyne and Greg Landsman want THC drinks taxed like alcohol, and Sen. Tim Sheehy spent Tuesday on camera framing hemp beverages as pain relief for Montana's seniors and veterans. None of it has had a hearing, yet. All of it is auditioning.

I take the licensed industry's grievance seriously, because it is structural and it is real. Those operators built to a rulebook. They paid for the vaults, the cameras, the tags, and the compliance staff, and they made their long-term plans on the premise that the rulebook was the price of admission. Hemp sprinted past all of it and proved concept at speed, with alcohol distributors, big-box retail, and genuine consumer uptake behind an estimated $28 billion in sales. That tension is legitimate, and pretending either side invented it helps no one. Here is what both lobbies keep talking past. The distinction between hemp and marijuana lives in statute and in plant taxonomy, and it dissolves somewhere on the trip to the register, where the shopper buying a THC seltzer in a four-pack has no reason to care that the licensed version of the same molecule sits in a vault under 24-hour camera coverage across town. Consumers are buying THC. December decides which shelf the law believes in. (MJBizDaily; Marijuana Moment; The Marijuana Herald)

🌴 Florida's medical registry passed 940,000 active patients for the first time, 940,116 as of August 28th, alongside a record 778 dispensing locations. The country's biggest medical program keeps growing in a state where 56 percent of voters said yes to adult-use two years ago and lost anyway, to the 60 percent supermajority the constitution demands. (Florida Office of Medical Marijuana Use data, via The Marijuana Herald)

The jury acquitted Suffolk County Sheriff Steven Tompkins on both extortion counts Wednesday, three and a half hours after getting the case. The government charged two theories, extortion by fear of economic harm and extortion under color of official right, both resting on the claim that Frank Perullo let Tompkins buy $50,000 of pre-IPO Ascend stock, then made him whole when it sank, because he feared for the company's Boston license. Martin Weinberg's one-witness defense had already established that the Cannabis Control Commission never threatened that license, formally or informally, and that Perullo, testifying under an immunity agreement, is nobody's pushover. "What I was accused of, I did not do," Tompkins said outside the courthouse. I was not in the jury room and I have not seen the full record, so I will not pretend to know whether the evidence should have cleared the bar. What the verdict establishes is plain enough. The U.S. Attorney's office swung at a sitting public official over a cannabis investment and missed on every count. And the trial put under oath something everyone in this industry suspects and rarely sees documented: relationships, friendships, and money travel alongside politics in every state, and the line between access and extortion belongs to a jury. Tompkins remains on leave, Mark Lawhorne remains acting sheriff, and what Suffolk County does with its returned sheriff is a political question the courtroom just handed back. (The Boston Globe; WBUR; GBH News)

🤝 Workers at NETA's Franklin, Massachusetts cultivation facility ratified a new contract with UFCW Local 1445 that the union says includes wage increases, a $700 ratification bonus, successorship protections, and notice requirements before new technology or AI reaches the floor. The technology notice language will get photocopied by bargaining units in other states. The contract text itself has not been released. (UFCW)

The Office of Cannabis Management began covering most Metrc tag costs for licensed businesses Tuesday, under a program funded through the state's 2026-27 enacted budget and announced in an August 28th bulletin. The allowances run by license type. Cultivators can hold up to 24,000 state-paid plant tags and 6,000 package tags, manufacturers, processors, distributors, and dispensaries up to 10,000 package tags each, laboratories 1,000, and qualifying manufacturers and processors up to 125,000 state-paid retail item IDs a month. Tags run a dime apiece under the state contract. Shipping and anything over the caps stay with the licensee, nobody gets reimbursed for tags bought before September 1st, and OCM projects the budget covers most inventory-tag expenses for twelve months. Track-and-trace is the state's own regulatory infrastructure, the ledger that makes every recall, audit, and enforcement case possible, and New York just decided to carry the cost of its own requirement for a year. After a compressed platform transition and a bruising twelve months of wage and cost fights, this is the least glamorous kind of good news a market can get, a regulator quietly making compliance cheaper for the people following the rules. Normalcy is a policy outcome too, and New York could use a year of it. (Office of Cannabis Management; The Marijuana Herald)

💸 Michigan's wholesale cannabis tax brought in $37.38 million in the second quarter, roughly $73.4 million since the January launch, against a $315 million consensus estimate for the fiscal year ending September 30th and an original legislative projection near $420 million a year. The repeal bill filed last month now has two quarters of arithmetic behind it. (Michigan Department of Treasury data, via Crain's Detroit Business; WJR)

Tulsa County District Attorney Steve Kunzweiler spent the week pressing for tougher oversight of Oklahoma's medical marijuana industry after the Sand Springs extraction explosion killed two men, and the Oklahoma Medical Marijuana Authority answered with a statement instead of a counterattack. The agency put the human tragedy first, named the full roster of agencies working the case, and stated its record plainly. Its most recent inspection found Solos Extract nonoperational with no illicit activity at the time, the licensed population has fallen below 4,000 from a peak near 13,000, and the agency has pursued at least 4,000 shutdown or administrative cases along the way. The criminal charges are running through the courts, where they belong. I have stood where OMMA is standing. A worker died in Massachusetts during my tenure, the investigation was active, and the public criticism arrived well ahead of the facts. Some of it was political ego and some of it I had earned, and from inside the building those two are nearly impossible to tell apart. What OMMA is doing is the job: say what you know, name what you regulate and what you do not, and let the investigators finish. When the dust settles, the outcome should be accountability and lessons, in that order, and a regulator that keeps its lane while the pressure is highest earns the standing to deliver both. (Oklahoma Medical Marijuana Authority; News On 6; KJRH)

🚗 Assemblymember Gail Pellerin put AB 2697 on hold after counting Senate votes and coming up short. The bill would have let local governments approve drive-thru windows at licensed cannabis retailers over the objection of the California Narcotic Officers' Association. Held is a status a sponsor can revisit, and curbside pickup stays legal statewide in the meantime. (Marijuana Moment)

Aurora's board filed its directors' circular Wednesday, unanimously recommending shareholders reject Curaleaf's $4-per-share offer and tender nothing. The argument is the balance sheet. Aurora reports $149 million in cash and no debt as of June 30th, against more than $1 billion in debt and lease liabilities at Curaleaf on the same date, and the board says the bid would hand a leveraged buyer control of that cash at a discount. A fairness opinion dated September 1st rides in the circular. Curaleaf answered within hours. "Not once has there been a counteroffer presented to us," CEO Boris Jordan said, pointing to a $500 million senior notes raise as evidence lenders trust the business. Every number in this exchange is advocacy in a contested deal, including the tidy ones. The special committee moved faster than its calendar required, saying no early, in writing, with a fairness opinion attached, which reads like a board that either has another path in mind or wants Curaleaf bidding against itself. The offer stays open into late November, German reimbursement rules are still doing more to set Aurora's value than either press release, and the next number that matters belongs to a shareholder, a rival, or a raise. (Aurora Cannabis; Curaleaf Holdings; Cannabis Business Times)

🌿 Mike Simpson, co-founder of Lovewell Farms, Rhode Island's only USDA-certified organic hemp farm, published commentary asking the candidates for attorney general whether they can tell regulated hemp from converted intoxicants, after outgoing Attorney General Peter Neronha signed two multistate letters backing the federal restrictions. "What we do not support is describing Rhode Island's regulated hemp industry as something that is harmful," Simpson wrote. He has a commercial stake and a fair point. Rhode Island already runs one of the tightest, but permissive hemp frameworks in the country, 1 milligram of THC per serving and 5 per package, a genuinely strong retail and consumption market that is due for an update, starting with those caps. (Rhode Island Current, via News From The States)

Judge Joshua Allison continued the cannabis industry's emergency motion to the morning of September 4th, finding the claimed harm not yet established and choosing to observe the rollout instead of stopping it. The timing is the whole story. Retailers moved onto NMS2S on September 1st, and BioTrack goes dark for good at 12:01 a.m. on the 4th, hours before the judge takes the bench. The state's BioTrack contract stays paid through September 15th at $23,127.50 a month, so the old system exists as a fallback for exactly as long as nobody needs one, and state rules bar transport whenever the mandated tracking system is down. The judge's posture is legally sound and operationally nerve-racking. Waiting for demonstrated harm before enjoining an agency's timeline is what courts do. It is also true that industry-wide platform cutovers go badly more often than they go well, and this one is a car moving fast toward a light that has already turned. If everything clears the intersection Friday morning, the state will call it good driving. From where the licensees sit, it will be hard to distinguish from luck. (KUNM)

🏪 Cresco Labs agreed to buy PharmaCann Penn and its nine operating Pennsylvania medical dispensaries for an aggregate $50 million in cash and a seller note. Pennsylvania did more than $1.1 billion in medical sales last year, and the deal still needs regulatory approvals before anyone reads market share off it. The announcement is the company's, including the word accretive. (Cresco Labs)

Researching accounts. Building lists. Writing sequences.

There's a better use of your team's time.

Apollo is the AI revenue engine that handles the busywork, so you can stay focused on selling.

Plus, everything you need is in one place:

Stop doing busywork and start building pipeline, faster.

With Apollo — the AI revenue engine powering 4M+ users.

Sign up for free

Policy, Decoded grows best when it's shared deliberately. Three referrals earns a sticker pack. Five earns How to Be Heard, our guide to making public comment that regulators actually read.

🎧 Listen on Spotify | 📬 The Sunday Read-In | ⚖️ Share with a colleague

Policy, Decoded reaches operators, investors, counsel and regulators every weekday morning. Three founding sponsorships are open.